154 related articles for article (PubMed ID: 9099961)
1. Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung.
Werle B; Jülke B; Lah T; Spiess E; Ebert W
Br J Cancer; 1997; 75(8):1137-43. PubMed ID: 9099961
[TBL] [Abstract][Full Text] [Related]
2. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.
Werle B; Lötterle H; Schanzenbächer U; Lah TT; Kalman E; Kayser K; Bülzebruck H; Schirren J; Krasovec M; Kos J; Spiess E
Br J Cancer; 1999 Oct; 81(3):510-9. PubMed ID: 10507778
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin B, plasminogenactivator-inhibitor (PAI-1) and plasminogenactivator-receptor (uPAR) are prognostic factors for patients with non-small cell lung cancer.
Werle B; Kotzsch M; Lah TT; Kos J; Gabrijelcic-Geiger D; Spiess E; Schirren J; Ebert W; Fiehn W; Luther T; Magdolen V; Schmitt M; Harbeck N
Anticancer Res; 2004; 24(6):4147-61. PubMed ID: 15736466
[TBL] [Abstract][Full Text] [Related]
4. Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissue.
Werle B; Ebert W; Klein W; Spiess E
Biol Chem Hoppe Seyler; 1995 Mar; 376(3):157-64. PubMed ID: 7612192
[TBL] [Abstract][Full Text] [Related]
5. Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking.
Schweiger A; Staib A; Werle B; Krasovec M; Lah TT; Ebert W; Turk V; Kos J
Br J Cancer; 2000 Feb; 82(4):782-8. PubMed ID: 10732746
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin B in infiltrated lymph nodes is of prognostic significance for patients with nonsmall cell lung carcinoma.
Werle B; Kraft C; Lah TT; Kos J; Schanzenbächer U; Kayser K; Ebert W; Spiess E
Cancer; 2000 Dec; 89(11):2282-91. PubMed ID: 11147599
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin B activity in human lung tumor cell lines: ultrastructural localization, pH sensitivity, and inhibitor status at the cellular level.
Spiess E; Brüning A; Gack S; Ulbricht B; Spring H; Trefz G; Ebert W
J Histochem Cytochem; 1994 Jul; 42(7):917-29. PubMed ID: 8014475
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of cathepsin B. Prognostic significance in human lung cancer.
Sukoh N; Abe S; Ogura S; Isobe H; Takekawa H; Inoue K; Kawakami Y
Cancer; 1994 Jul; 74(1):46-51. PubMed ID: 8004582
[TBL] [Abstract][Full Text] [Related]
9. Multiple forms of cathepsin B in human lung cancer.
Krepela E; Procházka J; Mynaríková H; Kárová B; Polák J; Cermák J; Roubková H
Int J Cancer; 1995 Mar; 61(1):44-53. PubMed ID: 7705933
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin B, thiols and cysteine protease inhibitors in squamous-cell lung cancer.
Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
Neoplasma; 1997; 44(4):219-39. PubMed ID: 9473776
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumors and lung parenchyma.
Sedo A; Krepela E; Kasafírek E
J Cancer Res Clin Oncol; 1991; 117(3):249-53. PubMed ID: 1674512
[TBL] [Abstract][Full Text] [Related]
12. Increased cathepsin B activity in human lung tumors.
Krepela E; Kasafírek E; Novák K; Viklický J
Neoplasma; 1990; 37(1):61-70. PubMed ID: 2320181
[TBL] [Abstract][Full Text] [Related]
13. pH Dependence of inhibitors targeting the occluding loop of cathepsin B.
Cathers BE; Barrett C; Palmer JT; Rydzewski RM
Bioorg Chem; 2002 Aug; 30(4):264-75. PubMed ID: 12392705
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
Marchetti A; Bertacca G; Buttitta F; Chella A; Quattrocolo G; Angeletti CA; Bevilacqua G
Clin Cancer Res; 1999 Aug; 5(8):2077-81. PubMed ID: 10473089
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of increased lung tumor tissue cathepsin B.
Ebert W; Knoch H; Werle B; Trefz G; Muley T; Spiess E
Anticancer Res; 1994; 14(3A):895-9. PubMed ID: 8074490
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin B and cysteine proteinase inhibitors in bronchoalveolar lavage fluid of lung cancer patients.
Lüthgens K; Ebert W; Trefz G; Gabrijelcic D; Turk V; Lah T
Cancer Detect Prev; 1993; 17(3):387-97. PubMed ID: 8402725
[TBL] [Abstract][Full Text] [Related]
17. Carboxypeptidases cathepsins X and B display distinct protein profile in human cells and tissues.
Kos J; Sekirnik A; Premzl A; Zavasnik Bergant V; Langerholc T; Turk B; Werle B; Golouh R; Repnik U; Jeras M; Turk V
Exp Cell Res; 2005 May; 306(1):103-13. PubMed ID: 15878337
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin B as a potential prognostic and therapeutic marker for human lung squamous cell carcinoma.
Gong F; Peng X; Luo C; Shen G; Zhao C; Zou L; Li L; Sang Y; Zhao Y; Zhao X
Mol Cancer; 2013 Oct; 12(1):125. PubMed ID: 24139065
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer.
Leinonen T; Pirinen R; Böhm J; Johansson R; Kosma VM
Histol Histopathol; 2008 Jun; 23(6):693-700. PubMed ID: 18366007
[TBL] [Abstract][Full Text] [Related]
20. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
Milman N; Pedersen LM
Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
